GALT insider transactions
Galectin Therapeutics Inc. (GALT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for GALT
- Chief Medical Officer Jamil Khurram exercised 568 shares at a strike of $1.23 and sold $1,761 worth of shares (568 units at $3.10) as part of a pre-agreed trading plan (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Brem Henry4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- New insider Brem Henry claimed no ownership of stock in the company (SEC Form 3)3 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Eldred Kary bought $810 worth of shares (300 units at $2.70), increasing direct ownership by 0.46% to 65,682 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Amendment: SEC Form 4 filed by President and CEO Lewis Joel4/A - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Carson Benjamin Sr4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Zordani Richard A. Jr.4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Jamil Khurram4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Freeman Kevin D4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Eldred Kary4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by President and CEO Lewis Joel4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Callicutt Jack W4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Shlevin Harold H.4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Omenn Gilbert S4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Amelio Gilbert F4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Schwartz Elissa J.4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Uihlein Richard E was granted 13,158 shares, increasing direct ownership by 0.13% to 10,332,676 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- President and CEO Lewis Joel decreased direct ownership by 7% to 776,260 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- President and CEO Lewis Joel converted options into 84,000 shares and sold $321,134 worth of shares (84,000 units at $3.82) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Financial Officer Callicutt Jack W converted options into 60,000 shares and sold $233,388 worth of shares (60,000 units at $3.89) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Medical Officer Jamil Khurram sold $99,408 worth of shares (25,499 units at $3.90), converted options into 60,000 shares and sold $132,994 worth of shares (34,501 units at $3.85) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Medical Officer Jamil Khurram exercised 8,125 shares at a strike of $1.23 and sold $33,089 worth of shares (8,125 units at $4.07) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Amendment: Director Freeman Kevin D bought $19,514 worth of shares (5,500 units at $3.55), increasing direct ownership by 11% to 55,269 units (SEC Form 4)4/A - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Amendment: Director Freeman Kevin D bought $19,514 worth of shares (5,500 units at $3.55), increasing direct ownership by 11% to 55,269 units (SEC Form 4)4/A - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Eldred Kary bought $2,611 worth of shares (700 units at $3.73), increasing direct ownership by 1% to 65,382 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Freeman Kevin D bought $19,514 worth of shares (5,500 units at $3.55), increasing direct ownership by 11% to 55,269 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Eldred Kary bought $2,611 worth of shares (700 units at $3.73), increasing direct ownership by 1% to 65,382 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- President and CEO Lewis Joel exercised 7,829 shares at a strike of $2.86 and sold $55,241 worth of shares (7,829 units at $7.06) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Medical Officer Jamil Khurram sold $136,872 worth of shares (19,442 units at $7.04) and exercised 14,963 shares at a strike of $2.37, closing all direct ownership in the company (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Shlevin Harold H. exercised 20,000 shares at a strike of $1.98 and sold $172,424 worth of shares (24,499 units at $7.04), decreasing direct ownership by 42% to 6,500 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Large owner 10x Fund, L.P. disposed of 24,000 shares and sold $204,335 worth of shares (30,681 units at $6.66) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Shlevin Harold H. exercised 19,793 shares at a strike of $4.16, sold $177,208 worth of shares (28,210 units at $6.28) and exercised 8,417 units of Common Stok at a strike of $4.16 (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Shlevin Harold H. sold $119,240 worth of shares (20,000 units at $5.96), sold $936,071 worth of shares (155,790 units at $6.01), exercised 151,790 shares at a strike of $2.31 and exercised 20,000 shares at a strike of $1.98, decreasing direct ownership by 26% to 11,206 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Amendment: Large owner 10x Fund, L.P. sold $920,855 worth of shares (162,069 units at $5.68) (SEC Form 4)4/A - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Large owner 10x Fund, L.P. sold $851,700 worth of shares (150,000 units at $5.68) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- President and CEO Lewis Joel exercised 22,463 shares at a strike of $2.39 and sold $136,366 worth of shares (22,463 units at $6.07) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Financial Officer Callicutt Jack W sold $478,849 worth of shares (77,920 units at $6.15) and exercised 77,920 shares at a strike of $1.53 (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Medical Officer Jamil Khurram sold $88,888 worth of shares (16,250 units at $5.47), sold $573,622 worth of shares (104,867 units at $5.47), exercised 83,000 shares at a strike of $2.35 and exercised 16,250 shares at a strike of $1.23, decreasing direct ownership by 83% to 4,479 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Large owner 10x Fund, L.P. sold $210,000 worth of shares (40,000 units at $5.25) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Financial Officer Callicutt Jack W exercised 5,291 shares at a strike of $1.46 and sold $31,884 worth of shares (5,291 units at $6.03), decreasing direct ownership by 3% to 7,614 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- President and CEO Lewis Joel exercised 1,867 shares at a strike of $2.39 and sold $11,252 worth of shares (1,867 units at $6.03) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- President and CEO Lewis Joel exercised 200 shares at a strike of $2.39 and sold $1,200 worth of shares (200 units at $6.00) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Financial Officer Callicutt Jack W exercised 600 shares at a strike of $1.60 and sold $3,600 worth of shares (600 units at $6.00) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- President and CEO Lewis Joel sold $95,342 worth of shares (15,720 units at $6.07) and exercised 15,720 shares at a strike of $2.39 (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Financial Officer Callicutt Jack W sold $173,778 worth of shares (28,629 units at $6.07), exercised 3,810 shares at a strike of $1.61, sold $15,386 worth of shares (2,560 units at $6.01), sold $7,512 worth of Commno stock (1,250 units at $6.01) and exercised 28,629 shares at a strike of $1.61 (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Large owner 10x Fund, L.P. sold $246,800 worth of shares (50,000 units at $4.94) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- 10x Fund, L.P. sold $76,500 worth of shares (25,000 units at $3.06) (SEC Form 5)5 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Chief Financial Officer Callicutt Jack W exercised 8,706 shares at a strike of $1.37 and sold $56,054 worth of shares (8,706 units at $6.44) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- President and CEO Lewis Joel exercised 14,000 shares at a strike of $2.39 and sold $89,048 worth of shares (14,000 units at $6.36) (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Eldred Kary bought $2,925 worth of shares (1,000 units at $2.92), increasing direct ownership by 2% to 64,682 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Freeman Kevin D bought $14,495 worth of shares (5,000 units at $2.90), increasing direct ownership by 11% to 49,769 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Large owner Czirr James C gifted 20,000 shares, acquired $6,000 worth of shares (1,000 units at $6.00) and exercised 323,125 shares at a strike of $2.16, increasing direct ownership by 41% to 1,045,541 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Czirr James C acquired $12,000 worth of shares (2,000 units at $6.00) and gifted 23,200 shares, decreasing direct ownership by 3% to 741,416 units (SEC Form 5)5 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- President and CEO Lewis Joel gave a grant of 56,420 shares, decreasing direct ownership by 6% to 832,592 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Shlevin Harold H.4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Zordani Richard A. Jr.4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- Director Uihlein Richard E was granted 32,520 shares, increasing direct ownership by 0.32% to 10,301,271 units (SEC Form 4)4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Schwartz Elissa J.4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Omenn Gilbert S4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)
- SEC Form 4 filed by Director Rubin Marc4 - GALECTIN THERAPEUTICS INC (0001133416) (Issuer)